RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CSPC Pharmaceutical Group Stock

CSPC Pharmaceutical Group Liabilities 2024

CSPC Pharmaceutical Group Liabilities

13.08 B CNY

Ticker

1093.HK

ISIN

HK1093012172

WKN

548183

In 2024, CSPC Pharmaceutical Group's total liabilities amounted to 13.08 B CNY, a 13.02% difference from the 11.57 B CNY total liabilities in the previous year.

CSPC Pharmaceutical Group Aktienanalyse

What does CSPC Pharmaceutical Group do?

CSPC Pharmaceutical Group Ltd. is a leading pharmaceutical company in China. It was founded in 1997 and specializes in the manufacturing of pharmaceutical raw materials, intermediates, and finished drugs. The company's product range covers various therapy areas and provides a variety of medications for patients worldwide. The company's business model is based on research, development, and production of pharmaceutical products for the mass market. In 2019, CSPC Pharmaceutical achieved a revenue of 9.9 billion USD. The company's products are represented in 24 countries worldwide and aim to improve people's lives through innovations in the healthcare sector. CSPC Pharmaceutical has various divisions, including its sister company CSPC Zhongqi Pharmaceutical Technology Co. Ltd., which specializes in innovative technologies for drug manufacturing. Other divisions include CSPC Weisheng Pharmaceutical Co. Ltd. for marketing and distribution in China, as well as CSPC Ouyi Pharmaceutical Co. Ltd. for the production of traditional Chinese medicines. The product range of CSPC Pharmaceutical is diverse and offers medications for various application areas. This includes cancer therapy with products such as Anastrozole tablets and Vinorelbine injection solution. In the field of cardiovascular diseases, CSPC Pharmaceutical offers Metoprolol Succinate tablets. Additionally, the company provides products for the treatment of pain and inflammation, such as Ibuprofen suspension and generic versions of Celecoxib. Another focus of the company is the research and production of antibiotics, which are important medications in the treatment of bacterial infections. CSPC Pharmaceutical produces a wide range of antibiotics in different dosage forms, including Cefazolin Sodium injection solutions and Cefalotin Sodium injection solutions. Throughout its history, CSPC Pharmaceutical has received various awards and certifications that confirm the high quality of its products. In 2019, the company was honored as the "Best Innovative Pharmaceutical Firm" at the Asia-Pacific Biotech Industry Awards. Furthermore, CSPC Pharmaceutical has obtained the ISO 9001:2015 Quality Management System certificate, and its products are approved by the US FDA, the European Medicines Agency, and the National Medical Products Administration in China. Overall, CSPC Pharmaceutical is an important player in the Chinese pharmaceutical market, offering a wide product range and increasing the level of innovation through research and development. With its continuous growth and efforts towards quality and innovation, CSPC Pharmaceutical will continue to play a significant role in the global healthcare market. CSPC Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing CSPC Pharmaceutical Group's Liabilities

CSPC Pharmaceutical Group's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating CSPC Pharmaceutical Group's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing CSPC Pharmaceutical Group's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

CSPC Pharmaceutical Group's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in CSPC Pharmaceutical Group’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about CSPC Pharmaceutical Group stock

What is the level of liabilities of CSPC Pharmaceutical Group this year?

CSPC Pharmaceutical Group has a debt balance of 13.08 B CNY this year.

What were the liabilities of CSPC Pharmaceutical Group compared to the previous year?

The liabilities of CSPC Pharmaceutical Group have increased by 13.02% increased compared to the previous year.

What are the consequences of high debt for investors of CSPC Pharmaceutical Group?

High liabilities can pose a risk for investors of CSPC Pharmaceutical Group, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in CSPC Pharmaceutical Group?

Low liabilities mean that CSPC Pharmaceutical Group has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of CSPC Pharmaceutical Group affect the company?

An increase in liabilities of CSPC Pharmaceutical Group can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of CSPC Pharmaceutical Group affect the company?

A decrease in the liabilities of CSPC Pharmaceutical Group can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of CSPC Pharmaceutical Group?

Some factors that can influence the liabilities of CSPC Pharmaceutical Group include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of CSPC Pharmaceutical Group so important for investors?

The liabilities of CSPC Pharmaceutical Group are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can CSPC Pharmaceutical Group take to modify the liabilities?

To change its liabilities, CSPC Pharmaceutical Group can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does CSPC Pharmaceutical Group pay?

Over the past 12 months, CSPC Pharmaceutical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CSPC Pharmaceutical Group is expected to pay a dividend of 0.28 CNY.

What is the dividend yield of CSPC Pharmaceutical Group?

The current dividend yield of CSPC Pharmaceutical Group is .

When does CSPC Pharmaceutical Group pay dividends?

CSPC Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of October, June, July, November.

How secure is the dividend of CSPC Pharmaceutical Group?

CSPC Pharmaceutical Group paid dividends every year for the past 17 years.

What is the dividend of CSPC Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.28 CNY are expected. This corresponds to a dividend yield of 5.15 %.

In which sector is CSPC Pharmaceutical Group located?

CSPC Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von CSPC Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CSPC Pharmaceutical Group from 11/20/2024 amounting to 0.16 CNY, you needed to have the stock in your portfolio before the ex-date on 10/31/2024.

When did CSPC Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of CSPC Pharmaceutical Group in the year 2023?

In the year 2023, CSPC Pharmaceutical Group distributed 0.2 CNY as dividends.

In which currency does CSPC Pharmaceutical Group pay out the dividend?

The dividends of CSPC Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CSPC Pharmaceutical Group

Our stock analysis for CSPC Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSPC Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.